| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.6M | +26.1% |
| Cost of Revenue | $7.0M | +40.2% |
| Gross Profit | $13.5M | +19.8% |
| R&D Expense | $10.9M | +21.2% |
| SG&A Expense | $9.6M | +9.7% |
| Operating Income | -$16.3M | -22.1% |
| Interest Expense | $81K | -91.7% |
| Income Tax | $0 | — |
| Net Income | -$16.4M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $27.6M | -49.0% |
| Short-term Investments | $9.9M | — |
| Accounts Receivable | $2.7M | +14.0% |
| Inventory | $9.3M | +88.4% |
| Current Assets | $51.2M | -17.3% |
| Total Assets | $55.5M | -15.4% |
| Current Liabilities | $6.8M | +42.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.2M | -27.3% |
| Capital Expenditures | $253K | +50.6% |
| Investing Cash Flow | -$10.7M | -6290.5% |
| Financing Cash Flow | $409K | -99.1% |
| Free Cash Flow | -$16.4M | -27.6% |
| -14.1% |
| EPS (Basic) | -$0.68 | +1.4% |
| EPS (Diluted) | -$0.68 | +1.4% |
| Long-term Debt |
| $9.9M |
| +0.6% |
| Total Liabilities | $18.6M | +10.8% |
| Stockholders' Equity | $36.9M | -24.4% |